120.98
전일 마감가:
$121.45
열려 있는:
$122.49
하루 거래량:
287.71K
Relative Volume:
0.50
시가총액:
$6.04B
수익:
$338.46M
순이익/손실:
$-310.96M
주가수익비율:
-18.53
EPS:
-6.53
순현금흐름:
$-132.82M
1주 성능:
+1.85%
1개월 성능:
-0.26%
6개월 성능:
+8.33%
1년 성능:
+33.65%
Axsome Therapeutics Inc Stock (AXSM) Company Profile
명칭
Axsome Therapeutics Inc
전화
(212) 332-3241
주소
ONE WORLD TRADE CENTER, 29TH FLOOR, NEW YORK
AXSM을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
AXSM
Axsome Therapeutics Inc
|
120.99 | 6.06B | 338.46M | -310.96M | -132.82M | -6.53 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
404.02 | 100.41B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
605.67 | 59.59B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
463.67 | 59.77B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
773.20 | 45.14B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
342.26 | 37.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Axsome Therapeutics Inc Stock (AXSM) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-09-03 | 재개 | Wells Fargo | Overweight |
2025-07-03 | 재개 | Morgan Stanley | Overweight |
2025-06-03 | 개시 | Oppenheimer | Outperform |
2025-04-07 | 개시 | Jefferies | Buy |
2025-02-11 | 개시 | Deutsche Bank | Buy |
2024-12-31 | 재확인 | Mizuho | Outperform |
2024-09-03 | 개시 | Wells Fargo | Overweight |
2024-08-06 | 업그레이드 | BofA Securities | Neutral → Buy |
2024-07-22 | 개시 | Needham | Buy |
2024-04-29 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
2024-03-19 | 개시 | Robert W. Baird | Outperform |
2024-02-06 | 개시 | UBS | Buy |
2024-01-25 | 개시 | RBC Capital Mkts | Outperform |
2023-12-13 | 개시 | Citigroup | Buy |
2023-08-08 | 업그레이드 | BofA Securities | Underperform → Neutral |
2023-01-05 | 개시 | Piper Sandler | Neutral |
2022-11-01 | 개시 | Loop Capital | Buy |
2022-09-07 | 재개 | Mizuho | Buy |
2021-08-10 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
2021-06-10 | 개시 | Berenberg | Buy |
2021-01-08 | 개시 | Jefferies | Buy |
2020-12-16 | 개시 | Mizuho | Buy |
2020-09-29 | 개시 | BofA Securities | Underperform |
2020-09-10 | 개시 | Morgan Stanley | Overweight |
2020-04-28 | 재확인 | H.C. Wainwright | Buy |
2020-04-14 | 개시 | Cowen | Outperform |
2019-12-30 | 재확인 | H.C. Wainwright | Buy |
2019-12-17 | 재확인 | H.C. Wainwright | Buy |
2019-12-16 | 재확인 | Guggenheim | Buy |
2019-10-16 | 개시 | Guggenheim | Buy |
2019-09-18 | 개시 | William Blair | Outperform |
2019-05-28 | 개시 | SunTrust | Buy |
2019-05-23 | 재확인 | H.C. Wainwright | Buy |
2019-04-08 | 개시 | SVB Leerink | Outperform |
2019-03-15 | 재확인 | H.C. Wainwright | Buy |
2016-10-03 | 재개 | Brean Capital | Buy |
2015-12-15 | 개시 | Cantor Fitzgerald | Buy |
2015-12-14 | 개시 | Ladenburg Thalmann | Buy |
모두보기
Axsome Therapeutics Inc 주식(AXSM)의 최신 뉴스
AXSM: New 'Buy' Rating from B. Riley Securities with $179 PT | A - GuruFocus
How Axsome Therapeutics Inc. (19X) stock trades after rate cuts2025 Support & Resistance & Intraday High Probability Setup Alerts - newser.com
Will Axsome Therapeutics Inc. (19X) stock deliver stable dividendsJuly 2025 Chart Watch & Risk Controlled Daily Trade Plans - newser.com
H.C. Wainwright maintains Axsome stock Buy rating, $190 target - MSN
Can Auvelity Drive Axsome's Growth Through the Rest of 2025? - The Globe and Mail
Obstructive Sleep Apnea Market Insights Highlight Expanding Outlook Till 2034, DelveInsight Evaluates | Apnimed, Eli Lilly and Company, Axsome Therapeutics/Jazz Pharmaceuticals, Bioprojet Pharma - Barchart.com
Obstructive Sleep Apnea Market Insights Highlight Expanding - openPR.com
Prediction: These 2 Under-the-Radar Stocks Could Beat the Market in the Next 5 Years - Mitrade
Prediction: These 2 Under-the-Radar Stocks Could Beat the Market in the Next 5 Years - The Motley Fool
Axsome Sues Apotex to Block Copies of Symbravo Migraine Drug - Bloomberg Law News
Can Axsome Therapeutics Inc. stock withstand economic slowdownJuly 2025 Recap & Pattern Based Trade Signal System - newser.com
Will Axsome Therapeutics Inc. (19X) stock outperform global peers2025 Top Gainers & Real-Time Market Trend Scan - newser.com
Axsome Therapeutics ($AXSM) Is Paying a $7.75M Settlement to Investors — Here’s How to Get Your Shar - TradingView
Piper Sandler Maintains Axsome Therapeutics(AXSM.US) With Buy Rating, Maintains Target Price $148 - 富途牛牛
Axsome Settles Investors' Drug Approval Suit For $7.8M - Law360
Axsome Therapeutics ($AXSM) $7.75M Investor Settlement - TradingView
Axsome Therapeutics and $AXSM Investors Finalise $7.75M Settlement Agreement - TradingView
Cantor Fitzgerald Has Weak Forecast for AXSM FY2026 Earnings - MarketBeat
Assenagon Asset Management S.A. Cuts Stake in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Axsome therapeutics COO Jacobson sells $1.15 million in shares By Investing.com - Investing.com Canada
Axsome therapeutics COO Jacobson sells $1.15 million in shares - Investing.com
Axsome Therapeutics (NASDAQ:AXSM) COO Mark L. Jacobson Sells 10,000 Shares - MarketBeat
Axsome to Settle Class Suit Over Migraine Drug for $7.75 Million - Bloomberg Law News
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Given Average Rating of "Buy" by Analysts - MarketBeat
Axsome Therapeutics (NASDAQ:AXSM) COO Sells $5,241,237.84 in Stock - MarketBeat
Pallas Capital Advisors LLC Purchases 2,492 Shares of Axsome Therapeutics, Inc. $AXSM - MarketBeat
10,400 Shares in Axsome Therapeutics, Inc. $AXSM Acquired by Strs Ohio - MarketBeat
Herriot Tabuteau Sells 15,254 Shares of Axsome Therapeutics (NASDAQ:AXSM) Stock - MarketBeat
Herriot Tabuteau Sells 27,907 Shares of Axsome Therapeutics (NASDAQ:AXSM) Stock - MarketBeat
Herriot Tabuteau Sells 19,719 Shares of Axsome Therapeutics (NASDAQ:AXSM) Stock - MarketBeat
Market Moves: Can Axsome Therapeutics Inc. continue delivering strong returnsTrade Risk Assessment & Stepwise Swing Trade Plans - khodrobank.com
Intech Investment Management LLC Boosts Position in Axsome Therapeutics, Inc. $AXSM - MarketBeat
How Investors May Respond To Axsome Therapeutics (AXSM) Showcasing Late-Stage CNS Pipeline Data at Psych Congress - Yahoo Finance
Voya Investment Management LLC Sells 3,742 Shares of Axsome Therapeutics, Inc. $AXSM - MarketBeat
Technical Analysis: Is Axsome Therapeutics Inc gaining market share2025 Support & Resistance & Consistent Profit Trading Strategies - خودرو بانک
Tech Rally: How does Axsome Therapeutics Inc compare to its peers2025 Stock Rankings & Fast Momentum Entry Tips - خودرو بانک
FY2026 EPS Estimates for AXSM Decreased by Cantor Fitzgerald - Defense World
Rhumbline Advisers Has $6.39 Million Stake in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Axsome Therapeutics COO sells shares for $5.2 million By Investing.com - Investing.com Australia
AQR Capital Management LLC Purchases 20,152 Shares of Axsome Therapeutics, Inc. $AXSM - MarketBeat
Axsome Therapeutics Inc (AXSM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):